Excedrin (migraine)

   
Google
 
Web NewDrugInformation.com

Excedrin (migraine)


Drug - Excedrin (migraine)
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetaminophen; Aspirin; Caffeine
Multiple ingredients are in alphabetical order.

Strength - 250MG;250MG;65MG
The potency of the active ingredient(s), Acetaminophen; Aspirin; Caffeine. May repeat for multiple part products.

Applicant - NOVARTIS
The firm name holding legal responsibility for Excedrin (migraine). The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020802
The FDA assigned number to Excedrin (migraine). Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Excedrin (migraine). Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 14, 1998
The date Excedrin (migraine) was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Excedrin (migraine). The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - OTC
The group or category of approved drugs Excedrin (migraine) is in. Format is RX, OTC, DISCN.

Applicant Full Name - Novartis Consumer Health Inc
The full name of the firm holding legal responsibility for the new application of Excedrin (migraine).

Excedrin (migraine)